Pulmonology

Clinical Validation in Dark Pigmented Individuals Finds CIRCUL™ Pulse Oximetry Ring Provides Reliable Oxygen Saturation Readings Addressing Potential Discrimination in Traditional Pulse Oximeters

Tuesday, February 23, 2021 - 7:00pm

The CIRCUL Ring clinical validation study, conducted at the Tongde Hospital of Zhejiang Province, China, compared simultaneous measurements for the CIRCUL Ring and an arterial blood gas (ABG) test from 12 individuals (4 Black, ~33% of total enrollment).

Key Points: 
  • The CIRCUL Ring clinical validation study, conducted at the Tongde Hospital of Zhejiang Province, China, compared simultaneous measurements for the CIRCUL Ring and an arterial blood gas (ABG) test from 12 individuals (4 Black, ~33% of total enrollment).
  • For Black individuals, 100 oxygen saturation measurements from the CIRCUL Ring showed excellent correlation with data obtained simultaneously from ABG testing for oxygen saturations ranging from 100% to 70%.
  • The ongoing COVID pandemic highlights the importance of monitoring individuals' blood oxygenation (SpO2) before, during, and after exposure or infection.
  • The CIRCUL Ring should not be used as the sole determinant in any therapy, diagnosis, or treatment of patients.

2020 Asthma Epidemiology Forecast to 2029 - Understand the Trends Shaping and Driving the Market - ResearchAndMarkets.com

Wednesday, February 10, 2021 - 4:29pm

For some people asthma is mild, but in severe cases, people can experience life-threatening asthma attacks (Mayo Clinic, 2018).

Key Points: 
  • For some people asthma is mild, but in severe cases, people can experience life-threatening asthma attacks (Mayo Clinic, 2018).
  • In most cases, the cause of asthma is unknown, and although there is no cure, medication can help control asthma (CDC, 2013).
  • The publisher's epidemiologists used age- and sex-specific lifetime diagnosed prevalence rates to forecast the lifetime diagnosed prevalent cases.
  • Develop business strategies by understanding the trends shaping and driving the global asthma market.

Dymedso establishes respiratory scientific advisory board

Wednesday, February 3, 2021 - 1:00pm

MONTREAL, Feb. 3, 2021 /PRNewswire/ -Dymedso Inc. ("Dymedso"), a Montreal-based medical technology company, is proud to announce the formation of its Respiratory Scientific Advisory Board, comprised of several key opinion leading international experts in respiratory medicine.

Key Points: 
  • MONTREAL, Feb. 3, 2021 /PRNewswire/ -Dymedso Inc. ("Dymedso"), a Montreal-based medical technology company, is proud to announce the formation of its Respiratory Scientific Advisory Board, comprised of several key opinion leading international experts in respiratory medicine.
  • The advisory board will be tasked with helping Dymedso shape the future direction of pulmonary treatments within the airway clearance device industry.
  • Led by Dr. Simon Phaneuf, emergency physician and Chief scientific officer at Dymedso, and Dr. Laura McIntosh, Human Cell Biologist, the board will advise Dymedso on how best to further develop its digitally-controlled Frequencer acoustic airway clearance device to meet the needs of patients across various conditions related to respiratory infections, particularly those requiring the most critical care.
  • The following renowned medical professionals have been named to the Dymedso Respiratory Scientific Advisory Board:
    Nauman Chaudary, MD, is a professor of medicine and director of the adult cystic fibrosis center at Virginia Commonwealth University (VCU).

Worldwide Spirometer Industry to 2026 - Featuring Medline Industries, Schiller & Vyaire Medical Among Others - ResearchAndMarkets.com

Tuesday, February 2, 2021 - 2:15pm

The Global Spirometer Market size is expected to reach $1.7 billion by 2026, rising at a market growth of 10.2% CAGR during the forecast period.

Key Points: 
  • The Global Spirometer Market size is expected to reach $1.7 billion by 2026, rising at a market growth of 10.2% CAGR during the forecast period.
  • A spirometer refers to a medical device, used for estimating the accurate lungs' functioning.
  • The inhaled and exhaled volume of air from the lungs is calculated after the maximum inhalation by the patient.
  • Commonly, a spirometer is used to examine the function of the lungs before surgery in order to predict the type of respiratory diseases.

Windtree Appoints Dr. Joseph Soffer to Lead Cardiovascular Clinical Development

Monday, February 1, 2021 - 9:30pm

"We are thrilled to welcome Joe to lead our cardiovascular clinical development efforts at such an important time for Windtree," said Dr. Steve Simonson, Chief Medical Officer at Windtree Therapeutics.

Key Points: 
  • "We are thrilled to welcome Joe to lead our cardiovascular clinical development efforts at such an important time for Windtree," said Dr. Steve Simonson, Chief Medical Officer at Windtree Therapeutics.
  • Joseph Soffer, M.D., F.A.C.C., is a Board-certified physician in Cardiology and Internal Medicine with over 30 years of combined experience in industry, clinical practice, and academia.
  • In this role, he led the U.S. and international clinical development for cardiology assets and pharmacovigilance activities for late-stage trials.
  • Windtree Therapeutics, Inc. is advancing multiple late-stage interventions for acute cardiovascular and pulmonary disorders to treat patients in moments of crisis.

Update to 01/26/21 COVI-MSC™ Press Release: Fourth Patient Also Released From Hospital Following Third Infusion of Stem Cells

Sunday, January 31, 2021 - 10:27pm

The primaryobjectiveis to evaluate the safety of intravenous infusion of allogeneic adiposeMSCcells in patients with COVID-19-induced ARDor ARDS.

Key Points: 
  • The primaryobjectiveis to evaluate the safety of intravenous infusion of allogeneic adiposeMSCcells in patients with COVID-19-induced ARDor ARDS.
  • On January 26, 2021, Sorrento announced the first three enrolledICU COVID-19 patientsweredischarged from the hospital withina weekofstartingCOVI-MSC infusions and a fourth patient just started the COVI-MSC treatment last Monday, January 25, 2021.
  • Dr. Eyad Almasri, Associate Professor of Medicine, Pulmonary, Critical Care and Sleep Medicine at UCSF Fresno, is the principal investigator in this ongoing study.
  • RTX has completed a phase IB trial for intractable pain associated with cancer and a phase 1B trial in osteoarthritis patients.

Auris Health Announces Publication of Results from BENEFIT Study of MONARCH® Platform in CHEST

Thursday, January 21, 2021 - 1:00pm

The study, called BENEFIT, evaluated the safety and feasibility of the MONARCH Platform, a first-of-its-kind robotic technology indicated for use in diagnostic and therapeutic bronchoscopic procedures.

Key Points: 
  • The study, called BENEFIT, evaluated the safety and feasibility of the MONARCH Platform, a first-of-its-kind robotic technology indicated for use in diagnostic and therapeutic bronchoscopic procedures.
  • Results of the study were published in CHEST, the official publication of the American College of Chest Physicians.
  • The MONARCH Platform localized targeted nodules using a combination of direct visualization, navigational guidance and radial endobronchial ultrasound (R-EBUS).
  • Results of the study demonstrated safety, with pneumothorax occurring in 2/54 (3.7%) of procedures, and placement of a chest tube required in 1/54 (1.9%) procedure.

National Jewish Health and Saint Joseph Hospital Launch Robotic Bronchoscopy Program

Thursday, January 14, 2021 - 4:00pm

"It's exciting to be able to offer patients with lung nodules an alternative to surgical biopsy," said Ellen Volker, MD, MSPH, Director of Interventional Pulmonology at National Jewish Health and interventional pulmonologist at Saint Joseph Hospital.

Key Points: 
  • "It's exciting to be able to offer patients with lung nodules an alternative to surgical biopsy," said Ellen Volker, MD, MSPH, Director of Interventional Pulmonology at National Jewish Health and interventional pulmonologist at Saint Joseph Hospital.
  • Dr. Volker explained that National Jewish Health and Saint Joseph Hospital are among the first in the U.S. to combine cone-beam CT technology with robotic bronchoscopy technology.
  • SCL Saint Joseph Hospital founded in Denver in 1873 by the Sisters of Charity Leavenworth was the first private hospital in Colorado.
  • Saint Joseph Hospital is part of SCL Health.

Cerecor Announces Successful Proof of Concept Data for CERC-002, a Unique LIGHT-Neutralizing Antibody, in Patients Hospitalized with COVID-19 ARDS

Tuesday, January 5, 2021 - 12:00pm

There were a total of 4 COVID-19 related deaths in patients on CERC-002 vs. 9 on placebo as of December 2020.

Key Points: 
  • There were a total of 4 COVID-19 related deaths in patients on CERC-002 vs. 9 on placebo as of December 2020.
  • All patients in this trial were hospitalized with COVID-19 associated pneumonia and mild-to-moderate acute respiratory distress syndrome (ARDS).
  • A prespecified subpopulation of patients 60 years of age showed similar improvement in the primary endpoint (n=33, OR = 3.38, p=0.054).
  • CERC-002-treated patients in the subpopulation of patients 60 years of age also had a shorter average hospital stay compared with placebo-treated patients.

TLC Announces Completion of US$15 Million Financing for Subsidiary InspirMed Inc.

Monday, January 4, 2021 - 10:00am

InspirMed is a newly established subsidiary of TLC specializing in the development of inhalable liposome formulation programs, such as TLC19 for the treatment of Coronavirus disease 2019 (COVID-19) as well as other programs for severe acute and chronic pulmonary diseases.

Key Points: 
  • InspirMed is a newly established subsidiary of TLC specializing in the development of inhalable liposome formulation programs, such as TLC19 for the treatment of Coronavirus disease 2019 (COVID-19) as well as other programs for severe acute and chronic pulmonary diseases.
  • Long before the emergence of COVID-19, TLC had already begun plans to apply its unique and proprietary technology platforms to lung diseases.
  • We are happy to have kicked off 2021 with the completion of financing for InspirMed, said TLC President George Yeh.
  • TLC has a diverse, wholly owned portfolio of therapeutics targeting areas of unmet medical need in pain management, ophthalmology, oncology, and infectious diseases.